Prostate Cancer

The 2024 Breakthroughs and Discoveries Panel brought together internationally renowned experts in the field of BRCA-related cancer research and care. A special thank you to our moderator, Jill Werman Harris for leading such a lively discussion, to Dr. Susan Domchek, MD for putting this panel together and to our panelists, Kenneth Offit, MD, MPH of Memorial Sloan Kettering, Clare Turnbull, MD, PhD of the Institute of Cancer Research in London, and H. Gilbert Welch, MD of Brigham and Women’s Hospital Center for Surgery and Public Health for their thoughtful insights. 

This holiday season, as you pass the turkey and stuffing, please also pass along the gift of knowledge. Share this video and our BRCA risk factor quiz (basser.org/quiz) with three people you love and ask them to share with three more. Through the power of family and friendship, we can save countless lives. 

Susan Domchek, MD, moderated this Central Synagogue panel with individuals across various communities discussing their BRCA mutations and the steps they have taken to reduce their risk.

Basser Center Executive Director, Susan Domchek, MD, and Justin Bekelman, MD, discussed how BRCA mutations affect men, including an increased risk of prostate cancer. Dr. Bekelman is an Associate Professor in the Department of Radiation Oncology at the University of Pennsylvania.

Basser Center Executive Director, Susan Domchek, MD, discussed understanding hereditary cancer risk and BRCA mutations, providing a comprehensive introduction for mutation carriers and their families with an emphasis on risk terminology and basic genetic concepts.

Penn Medicine oncologist and Basser Center researcher Vivek Narayan, MD, MS, discusses BRCA-related prostate cancer treatment, recent scientific innovations, and the importance of philanthropy.

Basser Center Genetic Counselor Jacquelyn Powers, MS, LCGC, discusses the basic of BRCA mutations in men and shares helpful information like associated cancer risk and typical screening recommendations.

The Basser Center’s virtual Breakthroughs and Discoveries panel brought together internationally renowned experts in the field of BRCA-related cancer research and care to discuss how discoveries in the lab translate to patient care.